Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Xiao Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3172-8606; OpenAlex author ID A5026256993. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
18
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 5 papers · 2022: 2 papers · 2023: 1 paper

Papers 10

  1. Dysfunctional epigenetic protein-coding gene-related signature is associated with the prognosis of pancreatic cancer based on histone modification and transcri… Co-author DOI 10.1038/s41598-022-27316-2↗
  2. The NF-κB/miR-488/ERBB2 axis modulates pancreatic cancer cell malignancy and tumor growth through cell cycle signaling. Last author DOI 10.1080/15384047.2022.2054257↗
  3. Single-cell sequencing and establishment of an 8-gene prognostic model for pancreatic cancer patients. Co-author DOI 10.3389/fonc.2022.1000447↗
  4. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer. Last author DOI 10.1016/j.pan.2021.01.011↗
  5. Wogonoside inhibits TNF receptor-associated factor 6 (TRAF6) mediated-tumor microenvironment and prognosis of pancreatic cancer. Last author DOI 10.21037/atm-21-4164↗
  6. Expressional and Prognostic Value of S100A16 in Pancreatic Cancer Via Integrated Bioinformatics Analyses. Co-author DOI 10.3389/fcell.2021.645641↗
  7. Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3389/fimmu.2021.728062↗
  8. Meta-analysis of the Diagnostic Performance of Circulating MicroRNAs for Pancreatic Cancer. Last author DOI 10.7150/ijms.52706↗
  9. Autophagy Regulatory Genes MET and RIPK2 Play a Prognostic Role in Pancreatic Ductal Adenocarcinoma: A Bioinformatic Analysis Based on GEO and TCGA. Last author DOI 10.1155/2020/8537381↗
  10. The role of interleukin-18 in pancreatitis and pancreatic cancer. First author DOI 10.1016/j.cytogfr.2019.11.001↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongwei Zhu · 6 shared papers, 2020–2022 · strength 0.91
  2. Wenzhe Gao · 5 shared papers, 2021–2022 · strength 0.74
  3. Wenzhi Guo · 2 shared papers, 2022–2023 · strength 0.41
  4. Yunfei Liu · 2 shared papers, 2021–2022 · strength 0.30
  5. Zhiqiang Li · 2 shared papers, 2019–2020 · strength 0.29
  6. Yun Wang · 1 shared paper, 2023 · strength 0.20
  7. Shuijun Zhang · 1 shared paper, 2022 · strength 0.20
  8. Xingyu Li · 1 shared paper, 2020 · strength 0.16
  9. Longjun Zang · 1 shared paper, 2021 · strength 0.16
  10. Dongjie Chen · 1 shared paper, 2021 · strength 0.16
  11. Hui Huang · 1 shared paper, 2021 · strength 0.16
  12. Duo Han · 1 shared paper, 2022 · strength 0.16
  13. Guangping Tu · 1 shared paper, 2021 · strength 0.14
  14. Hui Huang · 1 shared paper, 2021 · strength 0.14
  15. Cheng Peng · 1 shared paper, 2021 · strength 0.14
  16. Alexandr V. Bazhin · 1 shared paper, 2019 · strength 0.12
  17. Jan Goesta D’Haese · 1 shared paper, 2019 · strength 0.12
  18. Jens Werner · 1 shared paper, 2019 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.